1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. All News
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
Delayed London Stock Exchange  -  11:38 2022-07-05 am EDT
10764.00 GBX   -0.54%
01:00pEuropean Bourses Hammered by Recession Fears; Euro Falls to 20-Year Low
MT
11:46aGLOBAL MARKETS LIVE : J Sainsbury, Foxconn, JPMorgan, Comcast, Tesla...
09:51aASTRAZENECA : Buy rating from Deutsche Bank
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
All news about ASTRAZENECA PLC
01:00pEuropean Bourses Hammered by Recession Fears; Euro Falls to 20-Year Low
MT
11:46aGLOBAL MARKETS LIVE : J Sainsbury, Foxconn, JPMorgan, Comcast, Tesla...
09:51aASTRAZENECA : Buy rating from Deutsche Bank
MD
09:37aAstraZeneca to acquire TeneoTwo and its clinical-stage T-cell engager, strengthening ha..
AQ
06:23aASTRAZENECA : to acquire TeneoTwo and its clinical-stage T-cell engager, strengthening hae..
PU
06:20aMARKETSCREENER'S WORLD PRESS REVIEW : July 5, 2022
06:06aAstraZeneca to Acquire Cancer Drug Maker TeneoTwo
MT
05:55aPETER THIEL : Stock Futures Head Lower as Recession Fears Loom Large
DJ
03:43aAstraZeneca Moves to Boost Blood Cancer Pipeline Via $1.3 Billion TeneoTwo Acquisition
MT
03:30aAstraZeneca to Buy TeneoTwo in Up to $1.27 Billion Deal
MT
02:24aAstraZeneca to buy oncology firm TeneoTwo for up to $1.27 billion
RE
02:23aAstraZeneca To Buy TeneoTwo in Up tp $1.27 Billion Deal
MT
12:31aAstraZeneca to Buy TeneoTwo for Up to $1.27 Billion
DJ
07/01SECTOR UPDATE : Health Care Stocks Rebound Late
MT
07/01SECTOR UPDATE : Health Care Stocks Struggling for Direction
MT
07/01AstraZeneca Meets Primary Endpoints in Late-Stage Liver, Biliary Tract Cancers Trials
MT
07/01AstraZeneca Shares Data at EASL and ESMO World GI for IMFINZI® (durvalumab) Combination..
BU
07/01AstraZeneca Shares Data at EASL and ESMO World GI for IMFINZI® Combinations in Patients..
CI
07/01AstraZeneca Enters New 3-Year Agreement with Oxford Biomedica
MT
07/01New chronic kidney disease (CKD) study indicates that CKD is present in one out of ten ..
AQ
07/01Imfinzi plus chemotherapy significantly improved pathologic complete response in AEGEAN..
AQ
07/01Pharmaceutical companies still have the upper hand
07/01Oxford BioMedica Extends Agreement With AstraZeneca for Covid-19 Vaccine Facility
DJ
07/01Oxford Biomedica signs new deal to make AstraZeneca COVID shot
RE
07/01Oxford Biomedica, AstraZeneca Unit Ink Three-year Deal To Manufacture COVID-19 Vaccines
MT
07/01Oxford Biomedica signs new deal to make AstraZeneca COVID shot
RE
06/30COVID SCIENCE-Pausing methotrexate improves booster response; first-trimester of pregna..
RE
06/30IMFINZI® (durvalumab) Plus Chemotherapy Significantly Improved Pathologic Complete Resp..
BU
06/30AstraZeneca Says Phase 3 Trial Interim Data Show Imfinzi Plus Chemotherapy Improves Pat..
MT
06/30ASTRAZENECA : Imfinzi plus chemotherapy significantly improved pathologic complete respons..
PU
06/30Astrazeneca's Imfinzi Plus Chemotherapy Significantly Improves Pathologic Complete Resp..
CI
06/30S.Korea authorises AstraZeneca COVID therapy Evusheld for vulnerable people
RE
06/30AstraZeneca says Imfinzi combo shows promise in late-stage lung cancer trial
RE
06/30AstraZeneca's Late-stage Lung Cancer Drug Trial Shows Improved Pathologic Complete Resp..
MT
06/30AstraZeneca Announces Positive High-Level Results from A Planned Interim Analysis of th..
CI
06/30AstraZeneca Says Imfinzi Improved Pathologic Complete Response in Lung Cancer
DJ
06/29European ADRs Move Slightly Higher in Wednesday Trading
MT
06/29FTSE 100 Closes Down 0.2% as Uncertainty Persists
DJ
06/29FTSE 100 retreats from two-week high on slowdown worries
RE
06/29Taiwan to receive first doses of Novavax COVID vaccine this week
RE
06/29SK Bioscience Shares Advance on Covid-19 Vaccine Approval
DJ
06/28AstraZeneca and Merck - LYNPARZA (olaparib) Receives Positive Opinion From EU CHMP as A..
AQ
06/28Amref and AstraZeneca launch mobile clinics to support last mile COVID-19 vaccination e..
AQ
06/28Amref and AstraZeneca launch mobile clinics to support last mile COVID-19 vaccination e..
AQ
06/27European Union Recommends Approval for AstraZeneca and Daiichi Sankyo's Enhertu
CI
06/27Merck, AstraZeneca's Lynparza Obtains EMA's Committee Recommendation as Adjuvant Treatm..
MT
06/27Enhertu recommended for approval in the EU by CHMP for patients with HER2-positive meta..
AQ
06/27AstraZeneca Pharma India Sets Record Date for Fiscal 2022 Final Dividend
MT
06/27AstraZeneca Partner Daiichi Sankyo Says EMA's Committee Backs Approval of Trastuzumab D..
MT
06/27AstraZeneca's Lynparza, Enhertu Win EU Panel's Backing for Approval in Breast Cancer
MT
06/27AstraZeneca PLC Announces Lynparzar Ecommended for Approval in the EU by CHMP as Adjuva..
CI
06/27Trastuzumab Deruxtecan Recommends for Approval in the EU by CHMP for Patients with HER2..
CI
06/27AstraZeneca-Daiichi Sankyo Enhertu Breast Cancer Drug Is Recommended for EU Approval
DJ
06/27AstraZeneca Lynparza Breast Cancer Treatment Is Recommended for EU Approval
DJ
06/24AstraZeneca-Merck & Co's Lynparza Receives EU Panel's Positive Opinion for New Indicati..
MT
06/24Sanofi, GSK variant-specific COVID shot found effective against Omicron
RE
06/23AstraZeneca Says Health Canada Expands Approved of Breast Cancer Treatment Enhertu
MT
06/23EU watchdog backs Valneva's COVID shot as contract talks go on
RE
06/23AstraZeneca Drug Candidate to Treat Wilson Disease Meets Primary Endpoint in Phase 3 Tr..
MT
06/23AstraZeneca's Investigational Drug Meets Primary Endpoint for Wilson Disease
MT
06/23ALXN1840 Shows Rapid and Sustained Improvement in Copper Mobilization From Tissues, Pot..
BU
06/23ASTRAZENECA : ALXN1840 shows rapid and sustained improvement in copper mobilisation from t..
PU
06/22ADRs End Lower; ArcelorMittal, AstraZeneca Trade Actively
DJ
06/22European Medicines Agency Validates AstraZeneca-Daiichi Sankyo Application for Breast C..
MT
06/22AstraZeneca and Merck - Results From Phase 3 PROpel Trial of LYNPARZA (olaparib) Plus A..
AQ
06/22PROpel Phase III trial positive results of LYNPARZA (olaparib) plus abiraterone in 1st-..
AQ
06/22Improved outcome for prostate cancer patients in Phase III PROpel trial
AQ
06/22AstraZeneca Partner Daiichi Sankyo Says Type II Variation Application for Breast Cancer..
MT
06/22COVID-19 vaccine scheme for world's poorest pushes for delivery slowdown
RE
06/22Biocartis, AstraZeneca To Jointly Develop Companion Lung Cancer Diagnostic Test For Tag..
MT
06/22Biocartis Group NV Announces New Agreement with AstraZeneca for the Development and Mar..
CI
06/21AstraZeneca-Merck & Co.'s Lynparza Delays Prostate Cancer Progression In Late-stage Stu..
MT
06/21Merck, AstraZeneca Publish Phase 3 Data for Lynparza-Abiraterone Combo to Treat Prostat..
MT
06/21European Bourses Close in Green for Second Consecutive Day
MT
06/21Ionis Pharmaceuticals, AstraZeneca's Eplontersen Meets Primary, Secondary Endpoints in ..
MT
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on ASTRAZENECA PLC